Deferred Tax Assets, Valuation Allowance in USD of ABBOTT LABORATORIES from Q4 2015 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
ABBOTT LABORATORIES quarterly Deferred Tax Assets, Valuation Allowance history and change rate from Q4 2015 to Q4 2024.
  • ABBOTT LABORATORIES Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2024 was $1.66B, a 80.9% decline year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

ABBOTT LABORATORIES Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed
Q4 2024 $1.66B -$7.03B -80.9% 31 Dec 2024 10-K 21 Feb 2025
Q4 2023 $8.69B +$7.52B +643% 31 Dec 2023 10-K 21 Feb 2025
Q4 2022 $1.17B -$30M -2.5% 31 Dec 2022 10-K 16 Feb 2024
Q4 2021 $1.2B +$39M +3.36% 31 Dec 2021 10-K 17 Feb 2023
Q4 2020 $1.16B +$182M +18.6% 31 Dec 2020 10-K 18 Feb 2022
Q4 2019 $978M -$385M -28.2% 31 Dec 2019 10-K 19 Feb 2021
Q4 2018 $1.36B +$8M +0.59% 31 Dec 2018 10-K 21 Feb 2020
Q4 2017 $1.36B +$1.17B +617% 31 Dec 2017 10-K 22 Feb 2019
Q4 2016 $189M +$103M +120% 31 Dec 2016 10-K 16 Feb 2018
Q4 2015 $86M 31 Dec 2015 10-K 17 Feb 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.